• Cellvizio®
    • Overview
    • Education
    • Economics
    • Indications
      • Gastroenterology
        • Barrett’s Esophagus
        • Pancreatic Cysts
        • Gastric Disease
        • Inflammatory Bowel Diseases
        • Irritable Bowel Syndrome – Food Intolerance
        • Bilio-Pancreatic Strictures
        • Colorectal Lesions
      • Pulmonology
        • Lung Nodules
        • Lung Transplant
      • Urology
  • Investors
    • Overview
    • Events and Presentations
    • Financials
    • Governance
  • About Us
    • Our Story
    • Team
      • Board of Directors
      • Leadership Team
    • Join Us
    • Commercial Network
  • Newsroom
    • News
    • Events
    • Press Coverage
  • US
    • INT
    • FR
Appointment of Christophe Lamboeuf to the position of Chief Financial Officer

Appointment of Christophe Lamboeuf to the position of Chief Financial Officer

by Zina | Apr 5, 2018 | News

Mauna Kea Technologies has appointed Christophe Lamboeuf to the position of Chief Financial Officer. Christophe Lamboeuf succeeds Olivier Regnard, who is pursuing another opportunity in a different industry. In his role, Christophe Lamboeuf will be...
In Vivo Confocal Laser Endomicroscopy with Cellvizio® allows the discovery of a previously unknown human structure, the interstitium

In Vivo Confocal Laser Endomicroscopy with Cellvizio® allows the discovery of a previously unknown human structure, the interstitium

by Zina | Apr 3, 2018 | News

According to the publication in Nature Group’s Scientific Reports, this discovery may have significance in cancer metastasis and other diseases and could lead to new therapeutic approaches for cancer Mauna Kea Technologies today announced the publication of...
Scientists Have Discovered a New Organ in the Human Body. What is the Interstitium?

Scientists Have Discovered a New Organ in the Human Body. What is the Interstitium?

by Zina | Mar 27, 2018 | Press Coverage

The bubble wrap-like network only became visible when the pathologists used a new laser endoscope, called a confocal laser endomicroscope, that allowed them to see microscopic tissues in living people. Most studies of tissues missed the interstitium because they rely...
Cellvizio® obtains positive assessment from the Korean National Evidence-based healthcare Collaborating Agency (NECA)

Cellvizio® obtains positive assessment from the Korean National Evidence-based healthcare Collaborating Agency (NECA)

by Zina | Mar 15, 2018 | News

New Health Technology Assessment (nHTA) Committee recognizes confocal laser endomicroscopy as “safe and effective technology in application for esophagus, stomach, bile duct” New Health Technology status enables specific reimbursement codes for...
Mauna Kea Technologies Appoints Experienced Healthcare Executive, Molly O’Neill, to Board of Directors

Mauna Kea Technologies Appoints Experienced Healthcare Executive, Molly O’Neill, to Board of Directors

by Zina | Jan 16, 2018 | News

Mauna Kea Technologies announced the appointment of Molly O’Neill to the Company’s Board of Directors, effective immediately. She replaces Ms. Marie Meynadier who recently resigned from the Board. Her appointment is expected to be ratified by shareholders...
« Older Entries
Next Entries »

Articles récents

  • Mauna Kea Technologies Announces Largest Annual Pancreatic Cyst Consortium at Digestive Disease Week® 2025 
  • Publication of the 2024 Annual Financial Report 
  • Digestive Disease Week 2025
  • Mauna Kea Technologies Announces Another Milestone Year at Digestive Disease Week® 2025 with 8 Presentations Demonstrating the Clinical Value of Cellvizio® in Key Indications 
  • Mauna Kea Technologies Reports Full Year 2024 Results and Provides a Business Update 

Commentaires récents

No comments to show.

Company Info

About Us

Join Us

Contact Us

Legal

Legal notice

Privacy policy

Our websites

Cellvizio.net

cell-tolerance.com

Diagnosingbarretts.org

Diagnosingpancreaticcysts.org

Follow us

  • Follow
  • Follow
  • Follow
  • Follow
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}